Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
- 31 July 2008
- journal article
- research article
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 35 (1) , 87-92
- https://doi.org/10.1016/j.jsat.2007.08.004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate hydrochloride, buprenorphine, and methadoneJournal of Substance Abuse Treatment, 2006
- BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV InfectionJournal of General Internal Medicine, 2006
- Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.Journal of Consulting and Clinical Psychology, 2001
- Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.Journal of Consulting and Clinical Psychology, 2001
- Assessment of HIV RiskJournal of Addictive Diseases, 1998
- The NIMH Multisite HIV Prevention Trial: Reducing HIV Sexual Risk BehaviorScience, 1998
- Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenanceDrug and Alcohol Dependence, 1996
- A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependenceDrug and Alcohol Dependence, 1995
- Socially desirable responding and self‐reported HIV infection risk behaviors among intravenous drug usersAddiction, 1993
- Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior.Psychological Bulletin, 1990